Related Experiment Video
Updated: May 30, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
p16( INK4a) positively regulates cyclin D1 and E2F1 through negative control of AUF1
Huda H Al-Khalaf1, Dilek Colak, Maher Al-Saif
1Department of Biological and Medical Research, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Background:
The cyclin-D/CDK4,6/p16(INK4a)/pRB/E2F pathway, a key regulator of the critical G1 to S phase transition of the cell cycle, is universally disrupted in human cancer. However, the precise function of the different members of this pathway and their functional interplay are still not well defined.
Methodology/Principal Findings:
We have shown here that the tumor suppressor p16(INK4a) protein positively controls the expression of cyclin D1 and E2F1 in both human and mouse cells. p16(INK4a) stabilizes the mRNAs of the corresponding genes through negative regulation of the mRNA decay-promoting AUF1 protein. Immunoprecipitation of AUF1-associated RNAs followed by RT-PCR indicated that endogenous AUF1 binds to the cyclin D1 and E2F1 mRNAs. Furthermore, AUF1 down-regulation increased the expression levels of these genes, while concurrent silencing of AUF1 and p16(INK4a), using specific siRNAs, restored normal expression of both cyclinD1 and E2F1. Besides, we have shown the presence of functional AU-rich elements in the E2F1 3'UTR, which contributed to p16/AUF1-mediated regulation of E2F1 post-transcriptional events in vivo. Importantly, genome-wide gene expression microarray analysis revealed the presence of a large number of genes differentially expressed in a p16(INK4a) -dependent manner, and several of these genes are also members of the AUF1 and E2F1 regulons. We also present evidence that E2F1 mediates p16-dependent regulation of several pro- and anti-apoptotic proteins, and the consequent induction of spontaneous as well as doxorubicin-induced apoptosis.
Conclusion/Significance:
These findings show that the cyclin-dependent kinase inhibitor p16( INK4a) is also a modulator of transcription and apoptosis through controlling the expression of two major transcription regulators, AUF1 and E2F1.
Insights
The tumor suppressor p16(INK4a) controls cyclin D1 and E2F1 expression by stabilizing their mRNAs via AUF1 regulation. This reveals p16(INK4a) as a key regulator of cell cycle, transcription, and apoptosis.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Cancer Research
Background:
- The cyclin-D/CDK4,6/p16(INK4a)/pRB/E2F pathway is crucial for cell cycle regulation and frequently disrupted in cancer.
- The exact roles and interactions of pathway members, particularly p16(INK4a), remain incompletely understood.
Purpose of the Study:
- To elucidate the precise function of p16(INK4a) in regulating the expression of key cell cycle and transcription factors.
- To investigate the molecular mechanisms underlying p16(INK4a)-mediated control of gene expression and apoptosis.
Main Methods:
- Utilized human and mouse cell lines for experiments.
- Employed mRNA stabilization assays, RNA immunoprecipitation (RIP), RT-PCR, and siRNA-mediated gene silencing.
- Conducted genome-wide gene expression microarray analysis and apoptosis assays.
Main Results:
- Demonstrated that p16(INK4a) positively controls cyclin D1 and E2F1 expression by stabilizing their mRNAs through negative regulation of AUF1.
- Confirmed AUF1 binding to cyclin D1 and E2F1 mRNAs and showed that AUF1 downregulation increases gene expression.
- Identified p16(INK4a)-dependent regulation of numerous genes, including those in AUF1 and E2F1 regulons, and showed E2F1 mediates p16-dependent apoptosis induction.
Conclusions:
- p16(INK4a) functions not only as a cell cycle inhibitor but also as a modulator of transcription and apoptosis.
- These effects are mediated through the regulation of major transcription regulators AUF1 and E2F1, impacting mRNA stability and gene expression.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Positive Regulator Molecules
Positive Regulator Molecules
Anaphase Promoting Complex

